BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 35851711)

  • 21. Outcomes among acute heart failure emergency department patients by preserved vs. reduced ejection fraction.
    Sax DR; Rana JS; Mark DG; Huang J; Collins SP; Liu D; Storrow AB; Reed ME;
    ESC Heart Fail; 2021 Aug; 8(4):2889-2898. PubMed ID: 33978311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential Prognostic Impact of Atrial Fibrillation in Hospitalized Heart Failure Patients With Preserved Ejection Fraction According to Coronary Artery Disease Status - Report From the Japanese Nationwide Multicenter Registry.
    Temma T; Nagai T; Watanabe M; Kamada R; Takahashi Y; Hagiwara H; Koya T; Nakao M; Omote K; Kamiya K; Iwano H; Yamamoto K; Yoshikawa T; Saito Y; Anzai T
    Circ J; 2020 Feb; 84(3):397-403. PubMed ID: 32009066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rehabilitation Intervention in Older Patients With Acute Heart Failure With Preserved Versus Reduced Ejection Fraction.
    Mentz RJ; Whellan DJ; Reeves GR; Pastva AM; Duncan P; Upadhya B; Nelson MB; Chen H; Reed SD; Rosenberg PB; Bertoni AG; O'Connor CM; Kitzman DW
    JACC Heart Fail; 2021 Oct; 9(10):747-757. PubMed ID: 34246602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of perivascular fat attenuation on computed tomography and heart failure with preserved ejection fraction.
    Nishihara T; Miyoshi T; Nakashima M; Ichikawa K; Takaya Y; Nakayama R; Miki T; Ito H
    ESC Heart Fail; 2023 Aug; 10(4):2447-2457. PubMed ID: 37259241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and prognostic impact of non-cardiac co-morbidities in heart failure outpatients with preserved and reduced ejection fraction: a community-based study.
    Iorio A; Senni M; Barbati G; Greene SJ; Poli S; Zambon E; Di Nora C; Cioffi G; Tarantini L; Gavazzi A; Sinagra G; Di Lenarda A
    Eur J Heart Fail; 2018 Sep; 20(9):1257-1266. PubMed ID: 29917301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence and Prognostic Significance of Pulmonary Function Test Abnormalities in Hospitalized Patients With Acute Decompensated Heart Failure With Preserved and Reduced Ejection Fraction.
    Kawakami R; Nakada Y; Hashimoto Y; Ueda T; Nakagawa H; Nishida T; Onoue K; Soeda T; Watanabe M; Saito Y
    Circ J; 2021 Aug; 85(9):1426-1434. PubMed ID: 33867406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence and survival of hospitalized acute decompensated heart failure in four US communities (from the Atherosclerosis Risk in Communities Study).
    Chang PP; Chambless LE; Shahar E; Bertoni AG; Russell SD; Ni H; He M; Mosley TH; Wagenknecht LE; Samdarshi TE; Wruck LM; Rosamond WD
    Am J Cardiol; 2014 Feb; 113(3):504-10. PubMed ID: 24342763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute decompensated heart failure in a North Indian community hospital: Demographics, clinical characteristics, comorbidities and adherence to therapy.
    Onteddu SH; Wangchuk G; Sharma AJ; Mohan JC
    Indian Heart J; 2020; 72(1):27-31. PubMed ID: 32423557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Five-year mortality of heart failure with preserved, mildly reduced, and reduced ejection fraction in a 4880 Chinese cohort.
    Chen S; Huang Z; Liang Y; Zhao X; Aobuliksimu X; Wang B; He Y; Kang Y; Huang H; Li Q; Yao Y; Lu X; Qian X; Xie X; Liu J; Liu Y
    ESC Heart Fail; 2022 Aug; 9(4):2336-2347. PubMed ID: 35437939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trends in Hospitalizations and Survival of Acute Decompensated Heart Failure in Four US Communities (2005-2014): ARIC Study Community Surveillance.
    Chang PP; Wruck LM; Shahar E; Rossi JS; Loehr LR; Russell SD; Agarwal SK; Konety SH; Rodriguez CJ; Rosamond WD
    Circulation; 2018 Jul; 138(1):12-24. PubMed ID: 29519849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence and Outcomes of Acute Heart Failure With Preserved Versus Reduced Ejection Fraction in SPRINT.
    Upadhya B; Willard JJ; Lovato LC; Rocco MV; Lewis CE; Oparil S; Cushman WC; Bates JT; Bello NA; Aurigemma G; Johnson KC; Rodriguez CJ; Raj DS; Rastogi A; Tamariz L; Wiggers A; Kitzman DW;
    Circ Heart Fail; 2021 Dec; 14(12):e008322. PubMed ID: 34823375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Revascularization in ischaemic heart failure with preserved ejection fraction: a nationwide cohort study.
    Deo SV; Reddy YNV; Zakeri R; Karnib M; Selvaganesan P; Elgudin Y; Kilic A; Rubelowsky J; Altarabsheh SE; Osman MN; Josephson RA; Mohan SKM; Cmolik B; Simon DI; Rajagopalan S; Cleland JGF; Sahadevan J; Sundaram V
    Eur J Heart Fail; 2022 Aug; 24(8):1427-1438. PubMed ID: 35119162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Racial Differences and Temporal Obesity Trends in Heart Failure with Preserved Ejection Fraction.
    Caughey MC; Vaduganathan M; Arora S; Qamar A; Mentz RJ; Chang PP; Yancy CW; Russell SD; Shah SJ; Rosamond WD; Pandey A
    J Am Geriatr Soc; 2021 May; 69(5):1309-1318. PubMed ID: 33401338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute heart failure with mid-range left ventricular ejection fraction: clinical profile, in-hospital management, and short-term outcome.
    Farmakis D; Simitsis P; Bistola V; Triposkiadis F; Ikonomidis I; Katsanos S; Bakosis G; Hatziagelaki E; Lekakis J; Mebazaa A; Parissis J
    Clin Res Cardiol; 2017 May; 106(5):359-368. PubMed ID: 27999929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mode of Death Among Japanese Adults With Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction.
    Kitai T; Miyakoshi C; Morimoto T; Yaku H; Murai R; Kaji S; Furukawa Y; Inuzuka Y; Nagao K; Tamaki Y; Yamamoto E; Ozasa N; Tang WHW; Kato T; Kimura T
    JAMA Netw Open; 2020 May; 3(5):e204296. PubMed ID: 32379331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tobacco smoking in patients with heart failure and coronary artery disease: A 20-year experience at Duke University Medical Center.
    Grubb AF; Pumill CA; Greene SJ; Wu A; Chiswell K; Mentz RJ
    Am Heart J; 2020 Dec; 230():25-34. PubMed ID: 32980363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Contemporary epidemiology and treatment of hospitalized heart failure patients in real clinical practice in China].
    Wang H; Li YY; Chai K; Zhang W; Li XL; Dong YG; Zhou JM; Huo Y; Yang JF
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Nov; 47(11):865-874. PubMed ID: 31744275
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical characteristics of hospitalized heart failure patients with preserved, mid-range, and reduced ejection fractions in Japan.
    Shiga T; Suzuki A; Haruta S; Mori F; Ota Y; Yagi M; Oka T; Tanaka H; Murasaki S; Yamauchi T; Katoh J; Hattori H; Kikuchi N; Watanabe E; Yamada Y; Haruki S; Kogure T; Suzuki T; Uetsuka Y; Hagiwara N;
    ESC Heart Fail; 2019 Jun; 6(3):475-486. PubMed ID: 30829002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mild and moderate to severe early acute kidney injury following cardiac surgery among patients with heart failure and preserved vs. mid-range vs. reduced ejection fraction: A retrospective cohort study.
    Gao Y; Wang C; Li J; Ji B; Wang J; Yan F; Wang Y
    Eur J Anaesthesiol; 2022 Aug; 39(8):673-684. PubMed ID: 35791895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of Coronary Artery Disease in Heart Failure with Reduced Ejection Fraction at the Aga Khan University Hospital in Nairobi.
    Kimeu R; Jeilan M; Ngunga M
    Glob Heart; 2023; 18(1):56. PubMed ID: 37868128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.